Secondary lymphedema from cancer therapy.
Advocacy
Diagnosis
Genetics
Imaging
Lymphedema
Treatment
Journal
Clinical & experimental metastasis
ISSN: 1573-7276
Titre abrégé: Clin Exp Metastasis
Pays: Netherlands
ID NLM: 8409970
Informations de publication
Date de publication:
02 2022
02 2022
Historique:
received:
01
11
2020
accepted:
03
04
2021
pubmed:
6
5
2021
medline:
2
4
2022
entrez:
5
5
2021
Statut:
ppublish
Résumé
This manuscript is a summary of findings focusing on various aspects of secondary lymphedema specifically as a sequelae of treatment for cancer. The topic was addressed at a session held during the 8th International Congress on Cancer Metastasis that was unique a for the inclusion of patients with lymphedema and therapists joining physicians, healthcare professionals, and researchers in an effort to give an overview of secondary lymphedema following cancer therapy as well as highlighting the unknowns in the field. Lymphedema is defined and both diagnosis and incidence of cancer-related lymphedema are explored. Further, exploration of imaging options for lymphedema and information on the genetic research for patients with cancer-related secondary lymphedema are presented. Patient education and early detection methods are then explored followed by conservative treatment. Finally, an examination of surgical treatment methods available for patients with lymphedema is covered. Overall, this manuscript presents valuable information and updates for those not familiar with incidence, diagnosis, early detection, and rehabilitation of patients with cancer-related secondary lymphedema.
Identifiants
pubmed: 33950413
doi: 10.1007/s10585-021-10096-w
pii: 10.1007/s10585-021-10096-w
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
239-247Informations de copyright
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.
Références
International Society of Lymphology (2020) The diagnosis and treatment of peripheral lymphedema: 2020 consensus document of the international society of lymphology. Lymphology 53:3–19
Cormier JN, Askew RL, Mungovan KS, Xing Y, Ross MI, Armer JM (2010) Lymphedema beyond breast cancer: a systematic review and meta-analysis of cancer-related secondary lymphedema. Cancer 116(22):5138–5149
doi: 10.1002/cncr.25458
Shaitelman SF, Cromwell KD, Rasmussen JC, Stout NL, Armer JM, Lasinski BB, Cormier JN (2014) Recent progress in the treatment and prevention of cancer-related lymphedema. CA Cancer J Clin 65:55–81
doi: 10.3322/caac.21253
Tandra P, Kallam A, Krishnamurthy J (2019) Identification and management of lymphedema in patients with breast cancer. J Oncol Pract 15(5):255–262. https://doi.org/10.1200/JOP.18.00141
doi: 10.1200/JOP.18.00141
pubmed: 31009281
Lee MJ, Beith J, Ward L, Kilbreath S (2014) Lymphedema following taxane-based chemotherapy in women with early breast cancer. Lymphat Res Biol 12(4):282–288. https://doi.org/10.1089/lrb.2014.0030
doi: 10.1089/lrb.2014.0030
pubmed: 25411764
Stanton AW, Modi S, Bennett Britton TM, Purushotham AD, Peters AM, Levick JR, Mortimer PS (2009) Lymphatic drainage in the muscle and subcutis of the arm after breast cancer treatment. Breast Cancer Res Treat 117(3):549–557. https://doi.org/10.1007/s10549-008-0259-z
doi: 10.1007/s10549-008-0259-z
pubmed: 19052859
Asellius G (1627) De lactibus venis quarto vasorum mesaraicorum genere novo inuento, Mediolani. JB Biddellium. Reproduced in 1972 by Epistem Editrice, Milano
Natale G, Bocci G, Ribatti D (2017) Scholars and scientists in the history of the lymphatic system. J Anat 231(3):417–429
doi: 10.1111/joa.12644
Kinmonth JB (1972) The lymphatics: diseases, lymphography and surgery. Williams & Wilkins, Baltimore
Bernas M (2013) Imaging of the lymphatic system. Lymphedema management: the comprehensive guide for practitioners, 3rd edn. Thieme, New York
Witte CL, Witte MH, Unger EC, Williams WH, Bernas MJ, McNeill GC, Stazzone AM (2000) Advances in imaging of lymph flow disorders. Radiographics 20(6):1697–1719
doi: 10.1148/radiographics.20.6.g00nv141697
Jayaraj A, Raju S, May C, Pace N (2019) The diagnostic unreliability of classic physical signs of lymphedema. J Vasc Surg Venous Lymphat Disord 7(6):890–897. https://doi.org/10.1016/j.jvsv.2019.04.013
doi: 10.1016/j.jvsv.2019.04.013
pubmed: 31281100
Rasmussen JC, Kwon S, Sevick-Muraca EM, Cormier JN (2012) The role of lymphatics in cancer as assessed by near-infrared fluorescence imaging. Ann Biomed Eng 40:408–421. https://doi.org/10.1007/s10439-011-0476-1
doi: 10.1007/s10439-011-0476-1
pubmed: 22139396
Hwang JH, Choi JY, Lee JY, Hyun SH, Choi Y, Choe YS, Lee KH, Kim BT (2007) Lymphscintigraphy predicts response to complex physical therapy in patients with early stage extremity lymphedema. Lymphology 40:172–176
pubmed: 18365531
Yamamoto T, Matsuda N, Doi K, Oshima A, Yoshimatsu H, Todokoro T, Ogata F, Mihara M, Narushima M, Iida T, Koshima I (2011) The earliest finding of indocyanine green lymphography in asymptomatic limbs of lower extremity lymphedema patients secondary to cancer treatment: the modified dermal backflow stage and concept of subclinical lymphedema. Plast Reconstr Surg 128(4):314e–321e
doi: 10.1097/PRS.0b013e3182268da8
Yamamoto T, Yamamoto N, Doi K, Oshima A, Yoshimatsu H, Todokoro T, Ogata F, Mihara M, Narushima M, Iida T, Koshima I (2011) Indocyanine green-enhanced lymphography for upper extremity lymphedema: a novel severity staging system using dermal backflow patterns. Plast Reconstr Surg 128(4):941–947. https://doi.org/10.1097/PRS.0b013e3182268cd9
doi: 10.1097/PRS.0b013e3182268cd9
pubmed: 21681123
Aldrich MB, Rasmussen JC, Fife CE, Shaitelman SF, Sevick-Muraca EM (2020) The development and treatment of lymphatic dysfunction in cancer patients and survivors. Cancers (Basel) 12(8):2280. https://doi.org/10.3390/cancers12082280
doi: 10.3390/cancers12082280
Dori Y, Keller MS, Fogel MA, Rome JJ, Whitehead KK, Harris MA, Itkin M (2014) MRI of lymphatic abnormalities after functional single-ventricle palliation surgery. AJR 203:426–431
doi: 10.2214/AJR.13.11797
Dori Y (2016) Novel lymphatic imaging techniques. Tech Vasc Interv Radiol 19(4):255–261. https://doi.org/10.1053/j.tvir.2016.10.002
doi: 10.1053/j.tvir.2016.10.002
pubmed: 27993320
Rane S, Donahue PMC, Towse T, Ridner S, Chappell M, Jordi J, Gore J, Donahue MJ (2013) Clinical feasibility of noninvasive visualization of lymphatic flow with principles of spin labeling MR imaging: implications for lymphedema assessment. Radiology 269:893–902
doi: 10.1148/radiol.13120145
Brouillard P, Boon L, Vikkula M (2014) Genetics of lymphatic anomalies. J Clin Invest 124(3):898–904
doi: 10.1172/JCI71614
Leppänen VM, Brouillard P, Korhonen EA, Sipilä T, Jha SK, Revencu N, Labarque V, Fastré E, Schlögel M, Ravoet M, Singer A, Luzzatto C, Angelone D, Crichiutti G, D’Elia A, Kuurne J, Elamaa H, Koh GY, Saharinen P, Vikkula M, Alitalo K (2020) Characterization of ANGPT2 mutations associated with primary lymphedema. Sci Transl Med 12(560):eaax8013. https://doi.org/10.1126/scitranslmed.aax8013
doi: 10.1126/scitranslmed.aax8013
pubmed: 32908006
Michelini S, Vettori A, Maltese PE, Cardone M, Bruson A, Fiorentino A, Cappellino F, Sainato V, Guerri G, Marceddu G, Tezzele S, Bertelli M (2016) Genetic screening in a large cohort of Italian patients affected by primary lymphedema using a next generation sequencing (NGS) approach. Lymphology 49(2):57–72
pubmed: 29906362
Gordon K, Varney R, Keeley V, Riches K, Jeffery S, Van Zanten M, Mortimer P, Ostergaard P, Mansour S (2020) Update and audit of the St George’s classification algorithm of primary lymphatic anomalies: a clinical and molecular approach to diagnosis. J Med Genet 57(10):653–659. https://doi.org/10.1136/jmedgenet-2019-106084
doi: 10.1136/jmedgenet-2019-106084
pubmed: 32409509
Finegold DN, Schacht V, Kimak MA, Lawrence EC, Foeldi E, Karlsson JM, Baty CJ, Ferrell RE (2008) HGF and MET mutations in primary and secondary lymphedema. Lymphat Res Biol 6:65–68
doi: 10.1089/lrb.2008.1524
Finegold DN, Baty CJ, Knickelbein KZ, Perschke S, Noon SE, Campbell D, Karlsson JM, Huang D, Kimak MA, Lawrence EC, Feingold E, Meriney SD, Brufsky AM, Ferrell RE (2012) Connexin 47 mutations increase risk for secondary lymphedema following breast cancer treatment. Clin Cancer Res 18(8):1–9
doi: 10.1158/1078-0432.CCR-11-2303
Newman B, Lose F, Kedda M-A, Francois M, Ferguson K, Janda M, Yates P, Spurdle AB, Hayes SC (2012) Possible genetic predisposition to lymphedema after breast cancer. Lymphat Res Biol 10:2–13
doi: 10.1089/lrb.2011.0024
Fu MR, Conley YP, Axelrod D, Guth AA, Yu G, Fletcher J, Zagzag D (2016) Precision assessment of heterogeneity of lymphedema phenotype, genotypes and risk prediction. Breast 29:231–240
doi: 10.1016/j.breast.2016.06.023
Miaskowski C, Dodd M, Paul SM, West C, Hamolsky D, Abrams G, Cooper BA, Elboim C, Neuhaus J, Schmidt BL, Smoot B, Aouizeratet BE (2013) Lymphatic and angiogenic candidate genes predict the development of secondary lymphedema following breast cancer surgery. PLoS ONE 8(4):e60164
doi: 10.1371/journal.pone.0060164
Leung G, Baggott C, West C, Elboim C, Paul SM, Cooper BA, Abrams G, Dhruva A, Schmidt BL, Kober K, Merriman JD, Leutwyler H, Neuhaus J, Langford D, Smoot BJ, Aouizerat BE, Miaskowski C (2014) Cytokine candidate genes predict the development of secondary lymphedema following breast cancer surgery. Lymphat Res Biol 12(1):10–22
doi: 10.1089/lrb.2013.0024
Smoot B, Kober KM, Paul SM, Levine JD, Abrams G, Mastick J, Topp K, Conley YP, Miaskowski CA (2017) Potassium channel candidate genes predict the development of secondary lymphedema following breast cancer surgery. Nurs Res 66(2):85–94
doi: 10.1097/NNR.0000000000000203
Visser J, van Geel M, Cornelissen AJM, van der Hulst RRWJ, Qiu SS (2019) Breast cancer-related lymphedema and genetic predisposition: a systematic review of the literature. Lymphat Res Biol (online). https://doi.org/10.1089/lrb.2017.0083
doi: 10.1089/lrb.2017.0083
Boccardo F, Casabona F, De Cian F, Friedman D, Villa G, Bogliolo S, Ferrero S, Murelli F, Campisi C (2009) Lymphedema microsurgical preventive healing approach: a new technique for primary prevention of arm lymphedema after mastectomy. Ann Surg Oncol 16:703–708
doi: 10.1245/s10434-008-0270-y
Box RC, Reul-Hirche HM, Bullock-Saxton JE, Furnival CM (2002) Physiotherapy after breast cancer surgery: results of a randomized controlled study to minimise lymphedema. Breast Cancer Res Treat 75:51–64
doi: 10.1023/A:1016591121762
Kilgore LJ, Korentager SS, Hangge AN, Amin AL, Balanoff CR, Larson KE, Mitchell MP, Chen JG, Burgen E, Khan QJ, O’Dea AP, Nye L, Sharma P, Wagner JL (2018) Reducing breast cancer-related lymphedema (BCRL) through prospective surveillance monitoring using bioimpedance spectroscopy (BIS) and patient directed self-interventions. Ann Surg Oncol 25(10):2948–2952. https://doi.org/10.1245/s10434-018-6601-8
doi: 10.1245/s10434-018-6601-8
pubmed: 29987599
Koelmeyer LA, Borotkanics RJ, Alcorso J, Prah P, Winch CJ, Nakhel K, Dean CM, Boyages J (2019) Early surveillance is associated with less incidence and severity of breast cancer-related lymphedema compared with a traditional referral model of care. Cancer 125(6):854–862. https://doi.org/10.1002/cncr.31873
doi: 10.1002/cncr.31873
pubmed: 30521080
Armer JM, Hulett JM, Bernas M, Ostby P, Stewart BR, Cormier JN (2013) Best practice guidelines in assessment, risk reduction, management, and surveillance for post-breast cancer lymphedema. Curr Breast Cancer Rep 5(2):134–144
doi: 10.1007/s12609-013-0105-0
Kaufman DI, Shah C, Vicini FA, Rizzi M (2017) Utilization of bioimpedance spectroscopy in the prevention of chronic breast cancer-related lymphedema. Breast Can Res Treat 166:809–815. https://doi.org/10.1007/s10549-017-4451-x
doi: 10.1007/s10549-017-4451-x
Whitworth PW, Cooper A (2017) Reducing chronic breast cancer-related lymphedema utilizing a program of prospective surveillance with bioimpedance spectroscopy. Breast J 24(1):62–65. https://doi.org/10.1111/tbj.12939
doi: 10.1111/tbj.12939
pubmed: 29063664
Soran A, Ozmen T, McGuire KP, Diego EJ, McAuliffe PF, Bonaventura M, Ahrendt GM, DeGore L, Johnson R (2014) The importance of detection of subclinical lymphedema for the prevention of breast cancer-related clinical lymphedema after axillary lymph node dissection: a prospective observational study. Lymph Res Bio 12(4):289–294
doi: 10.1089/lrb.2014.0035
Ridner SH, Dietrich MS, Cowher MS, Taback B, McLaughlin S, Ajkay N, Boyages J, Koelmeyer L, DeSnyder SM, Wagner J, Abramson V, Moore A, Shah C (2019) A randomized trial evaluating bioimpedance spectroscopy versus tape measurement for the prevention of lymphedema following treatment for breast cancer: interim analysis. Ann Surg Oncol 26(10):3250–3259. https://doi.org/10.1245/s10434-019-07344-5
doi: 10.1245/s10434-019-07344-5
pubmed: 31054038
pmcid: 6733825
Lasinski BB, McKillip Thrift K, Squire D, Austin MK, Smith KM, Wanchai A, Green JM, Stewart BR, Cormier JN, Armer JM (2012) A systematic review of the evidence for complete decongestive therapy in the treatment of lymphedema from 2004 to 2011. PM&R 4(8):580–601
doi: 10.1016/j.pmrj.2012.05.003
Fu MR, Deng J, Armer JM (2014) Putting evidence into practice: cancer-related lymphedema. Clin J Oncol Nurs 18(Suppl):68–79
doi: 10.1188/14.CJON.S3.68-79
Tam K, Shen L, Munneke JR, Ackerson LM, Partee PN, Somkin CP, Andre M, Kutner SE, Thiadens SRJ, Kwan ML (2012) Clinician awareness and knowledge of BCRL in a large, integrated healthcare delivery setting. Breast Cancer Res Treat 131(3):1029–1038
doi: 10.1007/s10549-011-1829-z
Lighthouse Lymphedema Network; Shedding Light on Lymphedema. https://lighthouselymphedema.org/home2/ . Assessed on 10 March 2021
National Lymphedema Network (NLN). https://www.lymphnet.org . Assessed on 10 March 2021
American Lymphedema Framework Project (ALFP). https://www.alfp.org/ . Assessed on 10 March 2021
Granzow JW (2018) Lymphedema surgery: the current state of the art. Clin Exp Metastasis 35(5–6):553–558. https://doi.org/10.1007/s10585-018-9897-7
doi: 10.1007/s10585-018-9897-7
pubmed: 29980891
Suami H, Chang DW (2010) Overview of surgical treatments for breast cancer-related lymphedema. Plast Reconstr Surg 126(6):1853–1863
doi: 10.1097/PRS.0b013e3181f44658
Granzow JW, Soderberg JM, Kaji AH, Dauphine C (2014) Review of current surgical treatments for lymphedema. Ann Surg Oncol Ann Surg Oncol 21(4):1195–1201
doi: 10.1245/s10434-014-3518-8
Masia J, Pons G, Nardulli ML (2015) Combined surgical treatment in breast cancer-related lymphedema. J Reconstr Microsurg 32:16–27
doi: 10.1055/s-0035-1544182
Boccardo F, De Cian F, Campisi CC, Molinari L, Spinaci S, Dessalvi S, Talamo G, Campisi C, Villa G, Bellini C, Parodi A, Santi PL, Campisi C (2013) Surgical prevention and treatment of lymphedema after lymph node dissection in patients with cutaneous melanoma. Lymphology 46(1):20–26
pubmed: 23930438
Boccardo F, Valenzano M, Costantini S, Casabona F, Morotti M, Sala P, De Cian F, Molinari L, Spinaci S, Dessalvi S, Campisi CC, Villa G, Campisi C (2016) LYMPHA technique to prevent secondary lower limb lymphedema. Ann Surg Oncol 23(11):3558–3563. https://doi.org/10.1245/s10434-016-5282-4
doi: 10.1245/s10434-016-5282-4
pubmed: 27221358
Granzow JW, Soderberg JM, Dauphine C (2014) A novel two-stage surgical approach to treat chronic lymphedema. Breast J 20(4):420–422. https://doi.org/10.1111/tbj.12282
doi: 10.1111/tbj.12282
pubmed: 24943048
Granzow JW, Soderberg JM, Kaji AH, Dauphine C (2014) An effective system of surgical treatment of lymphedema. Ann Surg Oncol 21(4):1189–1194
doi: 10.1245/s10434-014-3515-y
Brorson H, Svensson H, Norrgren K, Thorsson O (1998) Liposuction reduces arm lymphedema without significantly altering the already impaired lymph transport. Lymphology 31:156–172
pubmed: 9949387